Characteristic | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Year of diagnosis | ||||||
2004–2010 | 1.000 | |||||
2011–2015 | 1.021 | 0.798—1.305 | 0.871 | |||
Age, years | ||||||
< 65 | 1.000 | 1.000 | ||||
≥ 65 | 1.328 | 1.049—1.681 | 0.018 | 1.318 | 1.039—1.672 | 0.023 |
Sex | ||||||
Male | 1.000 | 1.000 | ||||
Female | 0.694 | 0.543—0 0.887 | 0.004 | 0.651 | 0.508—0.836 | 0.001 |
Race | ||||||
White | 1.000 | 0.446 | ||||
Black | 1.202 | 0.875—1.653 | 0.256 | |||
Other | 0.901 | 0.564—1.441 | 0.663 | |||
Tumor grade | ||||||
I | 1.000 | 0.269 | ||||
II | 1.631 | 0.923—2.883 | 0.092 | |||
III | 1.543 | 0.854—2.787 | 0.150 | |||
Other | 1.334 | 0.730—2.439 | 0.349 | |||
Histology | ||||||
SCC | 1.000 | 0.009 | 1.000 | 0.006 | ||
AD | 0.453 | 0.264—0.777 | 0.004 | 0.426 | 0.245—0.749 | 0.002 |
Other | 0.318 | 0.045—2.269 | 0.253 | 0.362 | 0.050—2.624 | 0.315 |
T stage | ||||||
T 1 | 1.000 | 0.169 | ||||
T 2 | 0.776 | 0.563—1.071 | 0.123 | |||
T 3 | 0.742 | 0.466—1.181 | 0.208 | |||
T 4 | 1.047 | 0.793—1.382 | 0.748 | |||
N stage | ||||||
N0 | 1.000 | 1.000 | ||||
N1 | 1.419 | 1.122—1.793 | 0.003 | 1.378 | 1.091—1.761 | 0.008 |
Treatment | ||||||
RS | 1.000 | 1.000 | ||||
CRT | 1.119 | 0.831—1.505 | 0.459 | 0.955 | 0.704—1.295 | 0.766 |